| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |